PhD from State University of New York and postdoctoral fellow at Brown University, with over 30 years of experience in pharmaceutical research and development. Particularly skilled in DNA encoded compound screening technology, early cancer target calibration, and small molecule inhibitor compound screening. Currently, nearly 30 SCI papers have been published and over 10 patents have been obtained; Undertook or participated in multiple scientific and technological projects, including the NIH Fund, the National 863 Program, the National Torch Program, and the Jiangsu Provincial Science and Technology Program. In 2013, he was named a core member of the innovation team in Jiangsu Province, and in 2021, he was selected as a leading entrepreneur in the Feifeng Talent Plan.